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Abstract—The identification and quantification of markers in
medical images is critical for diagnosis, prognosis, and disease
management. Supervised machine learning enables the detection
and exploitation of findings that are known a priori after
annotation of training examples by experts. However, supervision
does not scale well, due to the amount of necessary training
examples, and the limitation of the marker vocabulary to known
entities. In this proof-of-concept study, we propose unsupervised
identification of anomalies as candidates for markers in retinal
Optical Coherence Tomography (OCT) imaging data without a
constraint to a priori definitions. We identify and categorize
marker candidates occurring frequently in the data, and demon-
strate that these markers show predictive value in the task of de-
tecting disease. A careful qualitative analysis of the identified data
driven markers reveals how their quantifiable occurrence aligns
with our current understanding of disease course, in early- and
late age-related macular degeneration (AMD) patients. A multi-
scale deep denoising autoencoder is trained on healthy images,
and a one-class support vector machine identifies anomalies in
new data. Clustering in the anomalies identifies stable categories.
Using these markers to classify healthy-, early AMD- and late
AMD cases yields an accuracy of 81.40%. In a second binary
classification experiment on a publicly available data set (healthy
vs. intermediate AMD) the model achieves an AUC of 0.944.
Index Terms—unsupervised deep learning, anomaly detection,
biomarker identification, optical coherence tomography
I. INTRODUCTION
The detection of diagnostically relevant markers in imaging
data is critical in medical research and practice. Biomarkers are
required to group patients into clinically meaningful subgroups
regarding disease, disease progression, or treatment response.
Imaging data provides a wealth of information relevant for
Copyright (c) 2017 IEEE. Personal use of this material is permitted.
However, permission to use this material for any other purposes must be
obtained from the IEEE by sending a request to pubs-permissions@ieee.org.
Manuscript received November,29,2017; revised August,08,2018; accepted
October, 13, 2018.
The financial support by the Christian Doppler Research Association,
the Austrian Federal Ministry for Digital and Economic Affairs and the
National Foundation for Research, Technology and Development, by the
Austrian Science Fund (FWF I2714-B31), and by IBM (2016-2017 IBM PhD
Fellowship Award, and Faculty Award) is gratefully acknowledged. A Tesla
K40 used for this research was donated by the NVIDIA Corporation.
P. Seebo¨ck, T. Schlegl, R. Donner and G. Langs are with the Com-
putational Imaging Research Lab, Department of Biomedical Imaging
and Image-guided Therapy, Medical University Vienna, Austria (email:
philipp.seeboeck@meduniwien.ac.at, georg.langs@meduniwien.ac.at)
P. Seebo¨ck, S.M. Waldstein, H. Bogunovic, S. Klimscha, B.S. Gerendas,
U. Schmidt-Erfurth and G. Langs are with the Christian Doppler Laboratory
for Ophthalmic Image Analysis, Vienna Reading Center, Department of
Ophthalmology and Optometry, Medical University Vienna, Austria. (email:
sebastian.waldstein@meduniwien.ac.at)
* corresponding author
this grouping in the form of imaging biomarkers. Typically,
image analysis methods are trained based on a priori defined
categories, and annotated imaging data. This makes large-
scale annotation necessary, which may be costly or infeasible,
limits detection to known marker categories, and, overall,
slows down the discovery of novel markers. In contrast,
unsupervised detection of anomalies and subsequent data-
driven identification of new markers offer the possibility for
unbiased classification of a disease and the identification of
novel risk factors. Unsupervised detection can extend our
knowledge about the underlying pathophysiology of diseases.
The resulting biomarkers can enable a description of the entire
spectrum of a disease, from the earliest manifestations to the
terminal stages [1]. In this proof-of-concept study, we perform
anomaly detection on retinal images to identify biomarker
candidates, categorize them, and evaluate their link to disease.
A. Clinical background
OCT [2] provides high-resolution, 3D volumes of the retina
and is the most important diagnostic modality in ophthalmol-
ogy. Approximately 30 million ophthalmic OCT procedures
are conducted per year worldwide, on par with imaging
modalities such as magnetic resonance imaging, computed
tomography, and positron emission tomography [3]. Each
position of the retina sampled by an optical beam results in a
vector, the A-scan. Adjacent A-scans form a 2D slice, alias B-
scan, which consecutively form the entire volume. Examples
of B-scans are shown in Fig. 2 on the left.
Retinal diseases causing vision loss affect many patients.
For instance, age-related macular degeneration (AMD) is the
leading cause of blindness in industrialized countries and has
a worldwide prevalence of 9% [4]. Even-though intraretinal
fluid shows some predictive value [5], we are lacking accurate
and reliable imaging markers and predictors for individual
patients disease courses. The discovery of novel reliable mark-
ers in imaging data is relevant to enhance individual care,
encompassing the identification and categorization of marker
candidates, and the quantification of their link to disease.
Not all patterns occurring in OCT volumes are understood
or interpretable, and for certain retinal diseases such as for
AMD [6], pathogenic mechanisms are not yet fully known.
Computational anomaly detection [7] and categorization is
a natural approach to tackle this problem, where the former
is defined as the detection of cases that differ from the
normal samples available during training. In retinal images
this is a difficult task for many reasons. In contrast to natural
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Fig. 1. Preprocessing of OCTs. (a) The original OCT scan with the top layer highlighted in blue and the bottom layer (Bruch’s membrane) in red. (b) The
same scan after normalization was applied (shift to horizontal plane, brightness, contrast). (c) A zoomed-in snippet of the over-segmentation result.
images, such as photographs, in retinal imaging the findings
relevant for diagnosis cover only a small fraction of the overall
volume. Furthermore, their deviation from normal tissue is
subtle compared to the variability of healthy retinas. Therefore,
to identify novel marker candidates, we form a model of
normal tissue variability, and detect anomalies deviating from
this model. In this paper, we define normal as the absence of
pathological changes beyond age-related alterations, i.e. the
only allowed visible alteration included drusen below 63 µm
in size according to the Beckman Initiative Classification [8].
This definition accounts for age-related changes that normally
do not result in visual impairment. For instance, the majority
of elderly patients shows small drusen, while still maintaining
normal vision.
Some retinal diseases such as retinal vein occlusion (RVO),
often occur unilaterally. Thus, the contralateral eye is not
affected by the acute event of the disease and can be elegantly
used as training data for the normal appearance model. In our
case, these volumes of contralateral eyes were screened by a
retinal specialist to rule out cases with pathological changes.
Since our model is purely trained on normal data, we omit
the need to collect a dataset containing a sufficient amount of
anomalies representing the entirety of their possible variability.
At the same time, the applicability of the model is not limited
to a specific disease.
B. Related Work
Anomaly detection can be a crucial first step in the process
of biomarker detection. The results of these algorithms are
affected by the quality of the features used for characterizing
the data. Supervised deep learning has recently improved the
state-of-the-art in various tasks, such as image classification
[9], object detection [10] or weakly supervised learning linking
semantic descriptions to image content [11]. It results in rich
feature representations, although at the cost of requiring large
amounts of annotated training samples and the limitation to
known markers. On the other hand, unsupervised learning en-
ables the exploitation of unlabeled data, capturing the structure
of its underlying distribution [12]–[15]. A well-known and
widely used technique for feature learning is Principal Compo-
nent Analysis (PCA) [16], which is computationally efficient,
but limited to a linear embedding. In contrast, unsupervised
deep learning of convolutional neural networks (CNNs) is
computationally more expensive, but can learn a non-linear
embedding.
In [13], unsupervised CNN training was performed by
discriminating between surrogate image classes created by
manually defined data augmentation to render the resulting
representation robust to certain transformations. Other studies
propose incorporation of supervisory signals such as spatial
context [12] to omit the requirement of manually annotated
data. In our study we identify clinically relevant biomarkers
without prior human input, which could bias the result.
The proposed anomaly detection method is inspired by the
combination of Deep Belief Networks (DBNs) with One-Class
SVMs for anomaly detection in real-life datasets, which have
considerably different characteristics compared to medical
images [17]. The DBNs learn a feature representation, while
the One-Class SVM finds a boundary describing regions in the
feature space with high probability density of the training data.
Erfani et al. [17] trained DBNs in a layer-wise fashion, and
did not use a multi-scale architecture, as we did. According to
[14], [15], the combination of joint training of layers and local
regularization constraints for each layer is more advantageous
than layer-wise training without constraints. Therefore, we
both trained the deep convolutional autoencoder (DCAE) [14]
and the deep denoising autoencoder (DDAE) [15] jointly. The
multi-scale architecture was partly inspired by [11], where
weakly supervised learning was used to link image information
to semantic descriptions of image content. Since DCAEs
are specifically designed to learn effective representation of
images, they are a logical comparison method when learning
unsupervised image representations. The idea of using normal
subjects to model a normal population is not novel. Sibide et
al. [18] modeled the appearance of normal OCT B-scans with
a Gaussian Mixture Model (GMM) and detected anomalous
B-scans as outliers. The number of outliers served as basis
for classification of an entire OCT volume. In contrast, we
aim at pixel level anomaly detection. In [19], a shape model
of normal retinal layers is used to segment anomalies. The
model has a close fit in normal regions, while there is no
fit in areas of anomalous shapes. The limitations of this
approach are that it heavily depends on the quality of the
layer segmentation algorithm and does not take into account
image information explicitly to detect anomalies. Finally,
Schlegl et al. [20] proposed AnoGAN, a deep convolutional
Generative Adversarial Network (GAN) to learn a manifold of
normal anatomical variability, in order to identify anomalous
regions in OCT images. AnoGAN is restricted to healthy
representations by definition, which makes it inappropriate for
a straightforward subsequent clustering step of anomalies. In
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contrast, we aim at learning a feature representation with our
autoencoder approach which is general enough to enable a
meaningful embedding of anomalies, though we solely need
normal training data.
Examples for the classic biomarker identification strategy
are [21], [22], where the authors used a priori defined features
in a supervised way to evaluate the applicability as biomarkers
for specific diseases. In contrary, our approach focuses on
identifying new marker candidates in an unsupervised way.
Regarding classification of retinal diseases on volume level,
main focus of related work [21], [23] is to solve the classi-
fication task itself. In contrast, here our target is to evaluate
the link of identified categories, alias marker candidates, to
disease by using them as features for classification.
C. Contribution
We propose a method to identify marker candidates in
imaging data in an unsupervised fashion. Our approach first
separates anomalous candidates from normal tissue in retinal
spectral-domain Optical Coherence Tomography (SD-OCT)
based on the features learned by DDAE on healthy sam-
ples, and a One-Class SVM to model normal appearance
distribution. We identify categories of frequently occurring
anomalies using clustering, and evaluate their link to disease.
In a qualitative evaluation, retinal experts could map part of
the categories identified by this approach to known retinal
structures. At the same time other categories remain as novel
anomaly candidates, for which results on the classification
tasks suggest that they are also linked to disease.
This paper is an extension of our previous work [24]
introducing a new feature-learning approach, and more in-
depth evaluation of anomaly detection, categorization, and the
link of these marker candidates to disease.
II. METHODS
To capture visual information at different levels of detail,
we used a multi-scale approach to perform superpixel-wise
segmentation of the visual input. While the preprocessing steps
are shown in Fig. 1, the overall architecture is illustrated
in Fig. 2. After preprocessing (Section II-A), 2D-patches
extracted from B-Scans from healthy OCT volumes were
used to train a deep denoising autoencoder model (Section
II-B), which provided an embedding that represented healthy
anatomical variability. A One-Class SVM was trained on
this embedding to obtain a boundary, which encompassed
the distribution of healthy patches (Section II-C). Using this
boundary, unseen volumes (i.e. volumes not used during train-
ing) were segmented into healthy or anomalous regions. Sub-
sequent clustering of anomalous regions partitioned anomalies
into more specific categories (Section II-D).
A. OCT Preprocessing
For all OCT volumes, we identified the top (Internal Limit-
ing Membrane - ILM) and bottom (Bruch’s Membrane - BM)
layer of the retina using a graph-based surface segmentation
algorithm [25], where the bottom layer was used to flatten
the retina by projecting it to a horizontal plane, as shown
in Fig. 1(b). The top and bottom layer of the retina are
also illustrated as blue and red in Fig. 2 at the bottom left.
This reduced the differences in appearance caused by varying
orientations and positions of the retina within the volume. We
applied brightness and contrast normalization for each B-scan
and added a constant to shift the values into a positive range.
The latter was necessary to ensure that the deep denoising
autoencoders (DDAE1, DDAE2) were able to reconstruct
the input patches (x˙, x¨) properly during training. Finally, we
performed over-segmentation of B-scans to monoSLIC super-
pixels, s, of an average size of 4×4 pixels [26], as illustrated
in Fig. 1(c). This merges pixels into homogeneous groups of
superpixels, which allows to perform the computations on a
reduced number of superpixels as opposed to computations on
every pixel.
Preprocessing of healthy B-scans, Ih, with h = 1, . . . ,H ,
resulted in Sh superpixels, shi , for each (as illustrated in
Fig. 1), with center positions phi and i = 1, . . . , S
h, where
H denotes the number of healthy B-Scans, Sh the number of
superpixels per B-Scan, i the index of the superpixel, and h
the index of the healthy B-Scan.
B. Unsupervised Learning of Appearance Descriptors
The network architecture of the deep denoising autoencoder
consists of an encoding and decoding part. We chose three
fully connected layers, with 2048 neurons in the first, 1024 in
the second, and 512 in the third layer to build the encoder,
with the structure also denoted as 2048f-1024f-512f.
The mirrored version of the encoder (512f-1024f-2048f)
formed the decoder, as illustrated in Fig. 2. The weight
matrices of two corresponding layers were tied: Wenc =WTdec.
All layers were followed by Exponential Linear Units (ELUs)
[27], with α = 1:
f(x) =
{
x if x > 0
α(exp(x)− 1) if x ≤ 0 (1)
The Mean Squared Error function, MSE(x, xˆ), was chosen
as a loss function for training, where x denotes the input
patch and xˆ the output of the last layer of the decoder. The
autoencoder was trained jointly in an end-to-end fashion, as
proposed in [15]. In addition, we added a local constraint
to each layer by corrupting the input of every layer in the
encoder. More precisely, a fraction of the inputs was set to
zero. As opposed to layer-wise training, this corresponds to
unsupervised joint training with local constraints in each layer.
We conducted unsupervised training of two deep denoising
autoencoders (DDAE1, DDAE2) on the patches, x˙hi and
x¨hi , extracted at center positions of superpixels p
h
i from the
healthy B-scans, Ih. While x˙hi = 32 × 32 served as input
for DDAE1, DDAE2 was trained with 128 × 32 patches
x¨hi , downsampled to 32 × 32. The provided patch sizes are
given in pixels. Both models were fixed for the subsequent
training of another denoising autencoder, DDAE3, its single-
layer architecture denoted as 256f, with the concatenated
feature vectors [y˙y¨] as input, where y˙hi = DDAE1(x˙
h
i )
and y¨hi = DDAE2(x¨
h
i ). All three learned encoders from
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Fig. 2. Multi-scale architecture used in the experiments. Pairs of x˙hi = 32 × 32 (green) and 128 × 32 (red) patches were extracted at positions phi in
healthy OCTs Ih from B-scans, where the larger patches were downsampled to x¨hi = 32 × 32, as illustrated on the left. The encoders of all unsupervised
learning modules are denoted in black, while the decoders are depicted in gray. Once learned, the encoders of DDAEent were used to create the new
feature representation zhi , for a specific superpixel s
h
i , with position p
h
i in the B-scan. Subsequent training of a One-Class SVM enabled the opportunity to
detect anomalous regions, a(sui ) = 1, in unseen B-scans Iu (i.e. B-Scans not used during training). In order to subdivide anomalous regions into meaningful
categories, cj , clustering was performed. This means that for each superpixel sui with position p
u
i in an anomalous region, a cluster assignment c(s
u
i ) was
performed. An example of anomaly detection and subsequent clustering of anomalous regions is shown on the top right.
DDAE1, DDAE2, and DDAE3 together formed the final
model, DDAEent, that gave us a 256 dimensional feature
representation, zhi = DDAEent(x˙
h
i , x¨
h
i ) = DDAEent(s
h
i ),
for a specific superpixel, shi , with corresponding patches
(x˙hi , x¨
h
i ) extracted at the central position of the superpixel,
phi . The multi-scale architecture allows to incorporate the local
information of the smaller patch and at the same time the
neighborhood and orientation information of the larger patch.
C. Anomaly Detection with One-Class SVM
Based on the learned feature representation, zhi , we esti-
mated the distribution of healthy examples with a One-Class
SVM [28], using a linear kernel. The SVM searches for a
boundary that describes the distribution of normal data, which
serves as a decision boundary for unseen data. New samples
can then be classified either as coming from the same data
distribution if lying inside the boundary (0, normal) or not (1,
anomaly). Since we used a linear kernel for One-Class SVM,
the only hyper-parameter was ν. This parameter determines
the amount of normal training data that must lie within the
boundary, i.e., which is detected as normal. For example, a
value of 0.1 means that 90% of the training samples are within
the boundary. In this work, we chose the parameter value with
the highest dice score on the validation set for the final model.
For unseen B-Scans, Iu, with u = 1, . . . , U , features zui
and the corresponding class a(zui ) = {0, 1} were computed
for each superpixel, sui , with position p
u
i within the top and
bottom layer of the retina, where U denotes the number of
unseen B-Scans. The computed class label a(zui ) was assigned
to the entire superpixel: a(zui ) = a(s
u
i ). This provided a
segmentation of the retina into two classes at superpixel level.
D. Categorization of Anomalous Regions
We used spherical K-means clustering [29] with cosine dis-
tance to sub-segment anomalous superpixels a(sui ) = 1, which
have been classified as anomalous by our method in the first
stage, in unseen B-Scans into C clusters, c(sui ) = c(z
u
i ) = j,
with j = 1, . . . , C. More precisely, we trained a cluster model
using the 256 dimensional feature representation z on an
”anomaly training set”, that was composed of samples with
a(zui ) = 1 only, to obtain cluster centroids cj . The number of
cluster centroids, C, was determined by an internal evaluation
criterion called the Davies-Bouldin (DB) index [30], calculated
on the anomaly training set. A small value indicates compact
and well-separated clusters, hence, the model with the smallest
DB index was selected.
To segment an unseen B-Scan Iu, each superpixel with the
property a(sui ) = 1 got a cluster assignment, c(s
u
i ), where
c(sui ) gives the index, j, of the nearest cluster centroid, cj . To
facilitate reading, we omitted indices i, h, and u henceforth.
III. EVALUATION
Our evaluation tests: (1) if the proposed algorithm can iden-
tify anomalous regions in imaging data, (2) if the algorithm
can detect stable categories of anomalies, and (3) if these
categories can serve as disease markers.
Data: We used n=786 OCT volumes from just as many
patients from our database, which was divided into six sub-
sets1: Healthy (training n=283, test n=33), late AMD (cate-
gorization n=362, validation n=5, test n=26), and early AMD
categorization n=77. The volumes of healthy training and test
were selected from 482 / 209 contralateral eye scans of patients
with RVO / AMD in the other eye. Volumes with pathological
changes beyond age-related alterations were excluded. The
1An overview of the data and experiments can be found in the supplemen-
tary material
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Original
Ground Truth
PCA256
{0.66, 0.63, 0.35, 0.34}
PCA0.95
{0.64, 0.71, 0.38, 0.32}
DCAE
{0.71, 0.67, 0.32, 0.36}
DDAEent
{0.68, 0.67, 0.37, 0.35}
Fig. 3. Anomaly detection: for each column, the same B-scan is illustrated, where red and blue colors indicate healthy and anomalous areas. To guarantee
objectivity, the first (last) two columns show examples with highest (lowest) dice of DDAEent. Dice values are provided for each method and sample. The
full quantitative evaluation result is given in Table I.
volumes of late AMD were eyes with active neovascular
AMD, where a retina specialist manually annotated all areas
that contained pathologic features in 31 OCT volumes. These
volumes with voxel-wise annotations of anomalous regions
were randomly divided into late AMD validation and late
AMD test. The volumes in early AMD categorization were
classified by clinical retina experts as early, non-neovascular
AMD according to [8]. All image data was anonymized and
ethics approval was obtained for the conduct of the study from
the ethics committee at the Medical University of Vienna.
The volumes were acquired using Spectralis OCT instru-
ments (Heidelberg Engineering, GER), with a voxel dimen-
sionality of 512 × 496 × 49, which depicted a 6mm ×
2mm× 6mm volume of the retina, with the voxel spacing of
11µm×4µm×120µm. Thus, one OCT volume is composed of
49 B-scans, where the distance between B-scans is 120µm. All
volumes were preprocessed as described in Section II-A. Due
to the anisotropy of the imaging data, the proposed approach
works with 2D patches extracted from B-scans. Pairs of image
patches with pixel size of 32×32 and 128×32 were extracted,
illustrated for a single position in Fig. 2, on the left.
Additionally, we used 384 Bioptigen SD-OCT volumes (269
intermediate AMD, 115 control) from a publicly available
dataset [21]. Since this dataset differs in appearance from
our database (different OCT vendor), we conducted additional
preprocessing steps: non-local means noise filtering, resizing
B-scans to match the Spectralis B-Scans in resolution, and
adjustment of image intensity values. Details can be found in
the supplementary material.
Training Details: All networks were trained on the
healthy training set for 300 epochs and used tied weights.
A validation set of five OCT volumes was used for param-
eter tuning. Due to limited computational resources, only a
small parameter selection was assessed. We used standard
values for ELU (α = 1), momentum (0.9), and mini-batch
(50). The initial learning rate was set to the highest value
that did not diverge (0.0001) for 150 epochs, and decreased
to 0.00001 for another 150 epochs. We experimented with
two different corruption values (0.5, 0.9) for fully connected
layers, and we found 0.5 to work better. We also conducted
experiments with shallower network architectures, which we
empirically found to work slightly worse. Since the One-
Class SVM hyper-parameter ν is bounded between 0 and
1, we varied ν between 0.01 and 0.9 for all methods: ν =
[0.01, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9]. For the experi-
ments we used the Torch7 framework [31] and the One-Class
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SVM implementation of libsvm [32].
A. Evaluation of Anomaly Detection
The anomaly detection model was trained on the healthy
training set, with 277340 extracted pairs of image patches,
randomly selected from all 13867 B-Scans between the top and
bottom layer of the retina to avoid retrieving numerous ”back-
ground patches” without relevant content. While the influence
of ν was analyzed on late AMD validation volumes, the final
performance of the learned anomaly detection model was
evaluated on late AMD test. Each B-scan of all validation and
test volumes was expert annotated between the ILM and BM
layer, and dice, precision, recall, specificity and accuracy were
calculated for algorithmically detected anomalous regions with
regard to the manual annotations on volume level.
We compared the DDAEent model to the feature learning
approaches described in Section I-B: PCA embedding, and
a Deep Convolutional Autoencoder, denoted as DCAE. PCA
was chosen since it is a well-known and widely used technique
for feature learning. At the same time we were aiming at a
powerful representation of images, which is why DCAEs, that
are specifically designed for images, are a logical comparison
method [14]. To ensure a fair comparison for PCA, we trained
two models. In the first model, PCA256, the dimensionality
was chosen to match the feature dimension, z, of the proposed
model. For both scales, the first 128 principal components
were kept. In the second model, PCA0.95, for each scale, the
first components that described 95% of the variance were kept.
To retrieve the final feature representation, the feature vectors
y˙ and y¨ of both scales were concatenated to obtain z.
For DCAE, we use an encoder with a convolutional layer
(c) and 512 9×9 filters, followed by a 3×3 non-overlapping
max pooling (p) and two fully connected layers with 2048
and 512 units (512c9-3p-2048f-512f). The decoder was
composed of deconvolution (dc) and unpooling (up) layers to
approximately invert the output of the encoder and reproduce
the input (512f-2048f-3up-512dc9). All layers, except
pooling and unpooling, were followed by ELUs. This DCAE-
architecture replaced DDAE1 and DDAE2, while the ar-
chitecture of the third model(DDAE3) remained the same.
To ensure a fair comparison, the feature dimension of the
individual model outputs matched the dimensionality of the
proposed method.
B. Evaluation of Anomaly Categorization
We trained two clustering models on two different datasets:
late AMD categorization and early AMD categorization. We
extracted 354760 and 75460 pairs of image patches, respec-
tively. For both models, we varied the number of clusters, C,
between 2 and 30 and selected the clustering model with low-
est DB-index. In order to qualitatively evaluate the categories
found in the regions identified as anomalous, a segmentation
of the retina based on the identified anomalous categories
was computed on both datasets. Assignment of each pixel
was based on the learned centroids and the nearest-cluster-
center labeling (Section II-D). The used manual annotations
of the test set provided only a binary distinction into healthy
and anomalous, and did not describe all anomalies that were
visible in separate categories. Therefore, two clinical retina
experts conducted a qualitative evaluation of the results by
visually inspecting the results. While the number of clusters
was determined by the DB-index, category descriptions were
identified by the experts. Additionally, cosine distances be-
tween centroids of the two cluster models trained on late AMD
categorization and early AMD categorization were computed
in order to evaluate the correspondence between both models.
C. Evaluation of Volume Level Disease Classification
To evaluate if the identified categories can serve as disease
markers and encode valuable discriminative information, we
used the segmentation of the retina into C clusters, originating
from the clustering model learned on late AMD categorization,
to conduct multi-class classification on patient level. The
volume of each cluster served as feature vector for every
case. Since the clusters that were identified in early AMD
categorization could all be mapped to clusters identified in
late AMD categorization, which at the same time revealed
one additional cluster, we used only the latter more complete
anomaly category set as basis for these experiments. We
trained a random forest (RF) classifier [33] (#trees=64) with
these feature vectors using a set of randomly chosen late
AMD, early AMD and healthy cases (n=50 per class) from the
training and categorization sets. We then applied the classifier
to a separate test set not involved in anomaly detection,
categorization, or classifier training composed of late AMD test
(n=26) the remaining part of early AMD categorization (n=27)
and healthy test (n=33). We report feature importance values
obtained by random forest training, and the classification
accuracy on the test set.
For comparison, we trained a second RF model without
category information. Using the same evaluation setting as
described above, we used the binary segmentation of the retina
as features, originating from anomaly detection (Section II-C),
instead of the learned clusters.
We performed a second experiment to evaluate how the
method generalizes to a dataset of a different vendor. The
Bioptigen volumes were used for a second volume classifica-
tion experiment. Following the evaluation procedure in [23],
the dataset was randomly divided into bioptigen training (218
AMD, 65 control) and bioptigen test (50 AMD, 50 control),
and the RF was trained with #trees=100. Again, we trained
two models with and without category information, originating
from the clustering model learned on late AMD categorization.
IV. RESULTS
We report quantitative and qualitative results that illustrate
anomaly detection, visualize anomaly categorization outcome,
provide descriptions of clusters according to experts and
describe results of volume disease classification tasks using
the identified categories as marker candidates.
A. Anomaly Detection Results
For the detection and segmentation of anomalies, the pro-
posed method achieved a dice of 0.53 between annotated and
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TABLE I
DICE, PRECISION, RECALL (=SENSITIVITY), SPECIFICITY, AND ACCURACY FOR ANOMALOUS
REGIONS WITH MANUAL ANNOTATIONS, CALCULATED ON THE TEST SET. ADDITIONALLY, THE
CHOSEN ν VALUE FOR THE ONE-CLASS SVM IS REPORTED.
Algorithm (ν) Dice Precision Recall Specificity Accuracy
PCA256 (0.4) 0.47 (0.12) 0.36 (0.12) 0.74 (0.09) 0.46 (0.03) 0.55 (0.05)
PCA0.95 (0.2) 0.51 (0.12) 0.40 (0.13) 0.74 (0.08) 0.56 (0.04) 0.62 (0.04)
DCAE (0.2) 0.49 (0.13) 0.41 (0.13) 0.64 (0.14) 0.63 (0.07) 0.65 (0.05)
DDAEent (0.1) 0.53 (0.09) 0.47 (0.12) 0.63 (0.06) 0.71 (0.07) 0.69 (0.05) Fig. 4. precision-recall curve, calculated on the
validation set.
predicted anomalous regions, a precision of 0.47, and a recall
of 0.63, which means that 63% of all manually annotated
anomalies were also identified as anomalous by our model
(Table I). PCA256, PCA0.95 and DCAE achieved a lower
Dice (0.47, 0.51, and 0.49) compared to our method. Using a
paired Wilcoxon signed-rank test, a significant difference could
be shown for PCA256 (p=0.0004) and DCAE (p=0.02), but
not for PCA0.95 (p=0.11).
To enable an objective qualitative evaluation, the volumes
which are visualized in Fig. 3 were selected according to
highest and lowest dice of DDAEent. An additional visual
comparison of the segmentation results revealed that the shape
of identified anomalous regions of the proposed method,
DDAEent, reflected the manual annotations better than all
comparison methods.
The validation performance for all examined ν values and
all methods is reported in Fig. 4 and Fig. 6. At a recall level
around 0.78, where the precision-recall curve (Fig. 4) seems
to reveal comparable performance of the examined methods,
DDAEent achieves a precision of 0.42, outperforming all
other approaches. At the same time, when comparing the
curves, it can be clearly observed that both DCAE and
DDAEent produced more stable results in comparison with
the PCA methods. In particular, Fig. 6 shows that preci-
sion/recall decreased/increased continuously as increased for
DCAE and DDAEent, while both PCA methods exhibited
an inconsistent behavior. In accordance with these quanti-
tative outcome, Fig. 5 illustrates segmentation results for
DDAEent and PCA0.95. Note that the embedding itself did
not change with varying ν values. This inconsistency of both
PCA methods makes an intuitive interpretation and adaption
of ν difficult, though it may be important for specific tasks to
control the precision-recall trade off.
B. Anomaly Categorization Results
Despite the fact that the anomaly detection performance
left room for improvement in general, the detected anomaly
candidates could be clustered into stable categories. The lowest
DB-index was found for C = 10 on late AMD categorization
and C = 9 on early AMD categorization, as indicated in
Fig. 7(a). This was a plausible outcome, since OCT volumes
with late AMD exhibit more obvious visual variation than
early AMD volumes.
The cosine distance between cluster centroids is visualized
in Fig. 7(b), where the columns were re-arranged for better
interpretability. The nearest-neighbors of cluster centroids are
illustrated in Fig. 7(c), both for late AMD and early AMD
clustering results. As can be seen both in 7(b) and (c), all
clusters of early AMD clustering could be linked to specific
clusters in late AMD clustering. This was a plausible outcome,
since all variation that is present in early AMD, is also present
in late AMD cases. Exemplary category descriptions identified
by experts are denoted in Fig. 7(d), where ”Upper boundary
of photoreceptor layer with pathologic surrounding” (a4, b4),
”Photoreceptor layer with pathologic surrounding” (a5, b5),
and ”vitreomacular interface with pathologic surrounding” (a9,
b9) could be identified in both clusterings.
In contrast, late AMD clustering showed one additional
cluster ”a10” which was identified as ”Exudative fluid” (e.g.
intraretinal or subretinal fluid) segmentation by the clinical
retina experts, and had no clear relation to a specific early
AMD cluster. This claim of missing relation was supported
by qualitative evaluation as well as by the calculated cosine
distance between cluster centroids, which showed relatively
low values (large distances) for ”a10” to all early AMD
clusters, as illustrated in Fig. 7(b), bottom row. Clustering
results are shown in Fig. 7 (e) on late AMD test B-scans, where
it can be seen that cluster ”a10” showed substantial overlap
with areas of fluid. Since fluid like intra- or sub-retinal fluid
occurs only in late AMD, this was a reasonable outcome and
indicated that also disease specific clusters had been learned.
C. Volume Level Disease Classification Results
We obtained an accuracy of 81.40% on the three-class
classification task, using the volume of each cluster (corre-
sponding to late AMD clustering) as features. The confusion
matrix (Fig. 8(a)) shows that the classifier could successfully
distinguish between late and early AMD cases. It is a more
difficult task to separate early AMD and healthy volumes2. The
feature importance, calculated during random forest training,
is given in Fig. 8(b). It visualizes how each feature contributes
to the prediction of a class in the form of the mean decrease
of accuracy (MDA) for individual feature perturbations. We
provide information about whether variables are positive or
negative predictors by comparing their average value within
class examples to the average value for out-of-class examples
as the sign. Results identify ”a7” as the most important
feature of the calculated random forest model. It is a strong
negative predictor for healthy, while a strong positive predictor
for late AMD. The comparison experiment without category
information resulted in lower accuracy of 60.47% on the same
classification task.
2Result examples can be found in the supplementary material.
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Fig. 5. Compared to the PCA methods, DDAEent produced more stable results when varying ν.
This finding was also supported by the segmentation results, illustrated for five consecutive ν values
of DDAEent and PCA0.95 on an example B-Scan (anomaly regions are highlighted in blue).
Fig. 6. Validation values of precision (dashed)
and recall (solid) are plotted against ν.
On the bioptigen test set, we achieved an area under the
ROC curve (AUC) of 0.944 (Figure 9) and 0.768 for the RF
models using category information or not, respectively. The
clear performance gaps on both classification tasks supports
the claim that the learned anomaly categories encode clinically
meaningful information. Furthermore, the result on bioptigen
test indicates that the learned feature representation and the
categories, respectively, reflect morphological properties of the
retina, and not OCT vendor specific characteristics.
V. DISCUSSION
We propose a method to detect and categorize anomalous
regions in OCT volumes of the retina, and subsequently use
these anomalies as marker candidates. The model is trained on
healthy imaging data and detects anomalies in new volumes
without constraints to a priori definitions. Categorization of
anomalies revealed clusters of frequently occurring patterns,
where a part of these categories could be mapped to clinically
meaningful entities in the imaging data in a post hoc qual-
itative assessment of clusters by experts. Finally, results in
disease classification tasks indicate that the identified marker
candidates encode valuable discriminative information.
a) Three insights: From evaluation results we gain three
primary insights. First, the proposed approach relying on
a multi-scale deep denoising auto encoder architecture to
represent image information shows comparable or superior
performance to alternatives such as PCA or DCAE. At the
same time, the embedding of DDAEent allows to control the
precision-recall trade off in an intuitive way, as opposed to
PCA. This indicates that the representation is important for
successful detection of subtle alterations in the imaging data
and stable training of the one-class SVM.
Second, we can identify stable categories, that are replicable
across data sets. Clustering reveals entities that are present in
late- and early AMD, and a class of entities that is only present
in late AMD. It demonstrates that purely data driven learning
can reveal meaningful structure in the data, that corresponds to
disease processes. Here, it reflects the emergence of exudative
liquid that is characteristic for late AMD.
Third, the identified anomaly categories are valid marker
candidates, that show predictive value, when used for volume
level classification.
b) Relationship to prior work: While we achieved an
AUC of 0.944 on the binary classification task, prior work
reported an AUC of 0.984 [23] and 0.992 [21] on the Bioptigen
dataset, where the latter used a different evaluation process
(leave-one-out cross-validation on all cases). In [23] features
are extracted at interest points which are located using man-
ually defined constraints, while Farsiu et al. [21] used semi-
automatically segmented retinal layers as features. In contrast
to our study, both works use prior knowledge about the disease
to create features specifically designed for this classification
task. Additionally, our features are generated by a model
which was trained on cases from a different OCT device
(Spectralis vs. Bioptigen), which adds additional complexity
to the task. Viewed in this light, our result indicates that
the learned anomaly categories encode valuable discriminative
information.
c) Identification of novel marker candidates: There is
strong interest in the identification of valid biomarkers in
AMD, since the already known biomarkers (e.g., retinal thick-
ness, macular fluid) do not explain the entire spectrum of
the disease and in particular the individual level of vision
loss [6]. The proposed method contributes a path to identify
novel marker candidates. It found categories that were known
(e.g. photoreceptor layer with pathologic surrounding, cluster
a5/b5), as well as potential new biomarker categories such
as ”a7”, which could not clearly be linked to a particular
known pathology by the clinical retina experts and at the
same time showed a high feature importance regarding dis-
ease classification. The ultimate aim is to use unsupervised
automated analysis to identify disease marker candidates in
a first step, as done in this study, and to define a precise
description of characteristics of those candidates in a second
step, transforming them from candidates to effective markers
applicable in clinical practice. The latter is subject of future
work, for instance by correlating marker candidates with visual
function. Results showing that the identified categories can
classify disease are the strongest indication that unsuper-
vised learning as proposed in this paper, can identify novel
marker candidates and potentially contribute to understanding
mechanisms governing disease course and treatment effect. If
accuracy of the method can be improved further, in addition
to marker identification, future work could also use anomaly
detection to quickly visualize anomalies in OCT volumes,
helping to efficiently evaluate large datasets, or in a screening
setting.
d) Limitations: There are some limitations that have
to be mentioned. First, the performance of the pixel-wise
anomaly detection (dice=0.53) left room for improvement.
While a recall of 0.63 indicates that manually annotated re-
gions were still missed in this step, the relatively low precision
of 0.47 may result from two sources: First, normal appearance
dissimilar to the range represented in the training set, due to
not having enough training data. The second possible source
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Fig. 7. Anomaly categorization: The calculated values of the DB-Index are plotted in (a). The cosine distance between cluster centroids is visualized in
(b) and is bounded between 0 and 1, due to rescaling of features into positive domain. The nearest-neighbors of cluster centroids are illustrated in (c). The
upper row shows the 32-by-32 patches, while the second row illustrates the 124-by-32 patches. Each cluster is indicated by a separate color. Some exemplary
cluster descriptions that were identified by experts are denoted in (d). Clustering results of late AMD and early AMD clustering are shown in (e) on example
B-scans, where identified anomalous regions were segmented into 10 and 9 categories, respectively. In accordance with former visualizations, normal regions
are highlighted in red.
may be anomalies that have not yet been categorized, and
are potential new candidates for markers. The interpretation
of identified marker candidates remains challenging. They do
not correspond to known categories, and thus no ground-
truth exists for their direct evaluation. Instead we use expert
description and classification experiments to verify and in-
vestigate their nature. Age information for individual patients
was not available in this study. However, the datasets were
composed of patients from multiple clinical studies, for which
the average study age was available. The computed mean ages
by weighting the mean ages of individual studies can be found
in the supplementary material. In principle, a younger age of
the healthy group could present a possible confounder in the
biomarker identification and evaluation process. However, our
data comes from clinical trials with a relatively high mean
age (65.9 or higher). Additionally, signs of normal aging in
OCT (i.e. mainly retinal pigment epithelium thinning [34])
are less pronounced than AMD related changes. Therefore,
we expect that in this study, our method primarily picks up
features associated with disease. A further limitation is that
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Fig. 8. Three-Class Classification: (a) Confusion matrix of the test set. (b) Identified anomaly categories as
markers of disease. The first three rows show the class-specific MDA, where the sign encodes the feature-trend
for that specific class (positive indicates high within class and low outside class values and vice versa). The
fourth row contains the MDA over all classes, and the last row shows the mean decrease in Gini index.
Fig. 9. ROC curve of the Bioptigen
binary classification task.
contralateral OCTs of patients with RVO/AMD in the other
eye were used as healthy training data. In order to minimize the
influence of this potential bias, retina experts conducted careful
selection of healthy OCTs within this data. There is a lack of
scientific consensus regarding where normal aging of the retina
stops and age-related disease starts. To address this limitation
and to account for age-related changes that normally do not
result in visual impairment, we have specifically included the
mildest category of age-related changes which include small
hard drusen (< 63µm) [8]. Another limitation is the restricted
informative value of feature importance values in the case
of low numbers of examples. A substantially higher number
of decision trees is necessary to obtain stable feature scoring
results compared to obtaining good classification accuracy. A
further limitation is that the evaluation was conducted with
AMD cases only, but, since the applicability of the proposed
method is not limited to a specific anomaly, an extension to
other diseases should be straightforward.
VI. CONCLUSION
We propose a method to segment anomalies in OCT
volumes and categorize these findings into disease marker
candidates. The detection of new anomalies, rather than the
automation of expert annotation of known anomalies, is a
critical shift in medical image analysis and particularly rel-
evant in retinal imaging. In this context, we introduced a
novel way to identify biomarker candidates, where results on
both classification tasks indicate that valuable discriminative
information is encoded in the newly identified categories.
Future work is needed to transform these categories from
candidates to actual markers applicable in clinical practice.
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